Comparison of Docetaxel/Prednisone to Docetaxel/Prednisone in Combination With OGX-011 in Men With Prostate Cancer (SYNERGY)
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT01188187 |
Recruitment Status :
Completed
First Posted : August 25, 2010
Last Update Posted : October 14, 2016
|
Sponsor:
Achieve Life Sciences
Collaborator:
Teva Branded Pharmaceutical Products R&D, Inc.
Information provided by (Responsible Party):
Achieve Life Sciences
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : | Completed |
---|---|
Actual Primary Completion Date : | February 2014 |
Actual Study Completion Date : | June 2014 |
Certification/Extension First Submitted : | October 7, 2016 |
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):